Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Brian Henick

Dr. Brian Henick

Medical Oncologist

Dr. Brian Henick is a medical oncologist at Columbia University Herbert Irving Comprehensive Cancer Center in New York City, where he focuses on improving treatment strategies for thoracic malignancies.

Get in touch
Jump to a Topic:

About Brian Henick

  • Immunotherapy icon


  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Board Certified icon

    Board Certified in Thoracic Surgery

Get to Know Dr. Brian Henick

Medical oncologist Dr. Brian Henick specializes in thoracic malignancies, including lung cancer and mesothelioma, and in personalizing patient care through novel therapeutics.

Henick believes in a multidisciplinary approach to treatment that includes the computational study of cancer immunobiology, the latest advancement in cancer care.

With every patient he serves, his goal is improving the current treatment strategy by maximizing the vast resources of one of the country’s leading cancer centers and its mesothelioma doctors.

Learn More About Mesothelioma Treatment

The National Cancer Institute has recognized the Columbia University Herbert Irving Comprehensive Cancer Center as an elite Comprehensive Cancer Center for more than 30 years.

Henick takes pride in staying attuned to the values and needs of each individual. His areas of treatment expertise include esophageal cancer and thymoma through the field of hematology.

He also serves as an associate professor of medicine at the Columbia University Irving Medical Center.

Specialties of Dr. Brian Henick

  • Immunotherapy
  • Lung cancer
  • Pleural mesothelioma
  • Esophageal cancer
  • Hematology
  • Oncology
  • Thoracic cancers

Dr. Brian Henick’s Experience and Medical Education

  • Columbia University Herbert Irving Comprehensive Cancer Center
  • Yale New Haven Hospital (Fellowship, residency, internship)
  • Rutgers New Jersey Medical School

Awards and Other Recognitions

  • ASCO Journals Editorial Fellowship
  • Conquer Cancer/ASCO Foundation Merit Award
  • Conquer Cancer/ASCO Young Investigator Award
  • Society for Immunotherapy of Cancer Sparkathon
  • Gold Humanism Honor Society

Publications of Dr. Brian Henick

  • Henick, B. (2020, February 11). Elite Intratumoral T-cell Clonotypes (The 1%) Effect “Trickle-Down Cytotoxicity.” Clinical Cancer Research.
  • Zugazagoitia, J. et al. (2019, October 9). Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer. Journal of Thoracic Oncology.
  • Henick, B. et al. (2014, December 18). The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer. Expert Opinion on Thoracic Targets.

Disclaimer: Dr. Brian Henick has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Columbia University Irving Medical Center. (n.d.). Brian Henick, MD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 7, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now